Trend A single treatment opens a wider pathway of behaviour, support, and spending

Summary

PwC treats GLP-1 weight-management drugs as the template for how one health signal expands into a broader pathway that carries behaviour change, surrounding support services, and additional spending well beyond the original prescription.

Classification

Main topicBio & Health Tech

Secondary topicsWelfare & Health Values & Lifestyles

Region menusGlobal

Impactscope:global

Time horizon0-3 years (2026-07-26)

Last updated2026-07-29 04:49:52

Evidence 1

Voice of the Consumer 2026: The rise of everyday health PwC page=10;section=GLP-1s show what can happen next 2026-06 accessed 2026-07-26

Observed signals 2

SignalGLP-1 adoption pushes demand towards smaller portions and higher-protein formats
SignalGLP-1 users track fibre, protein, and calories more and plan to spend more on health

Part of issues 1

IssueDemand outruns the care pathway, pushing patients into channels of their own2 trends · 1 signals

Relation types: constitutes · supports

Public id: fm-729ecea32411